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Since the first experimental studies by Bigelow and coworkers in theearly 1950s, the use of hypothermic circulatory arrest (HCA) hasbecome the standard technique for the surgical repair of certaincongenital and acquired cardiovascular lesions. The outcome afterthese operations improved considerably over the past two decades andsurgery requiring HCA can usually be performed with an acceptable
risk for the patient. However, it is likely that these improvements are more a
consequence of an increasing expertise with this type of surgery, rather than the
influence of one particular organ protection method employed. Despite this fact,
there is still room for improvement, since prolonged periods of HCA are still
associated with significant morbidity and mortality.
HCA and Multiorgan Dysfunction
The rationale for the use of HCA during cardiopulmonary bypass is based on the
reduction of the metabolic rate of the tissues and the subsequent increase of the
tolerance to ischemia. As the brain is the organ most sensitive to ischemic damage,
it is considered to be the limiting factor for the duration of HCA. Nevertheless,
despite its protective effects, HCA can be detrimental for other organ systems.
Cooper and coworkers,1 using a porcine model, were able to demonstrate that HCA
was associated with endothelial dysfunction in the cerebral microvasculature as well
as in large-caliber renal arteries and pulmonary veins. In addition, elevated liver and
pancreatic serum enzyme levels can be clinically observed after prolonged periods
of HCA (our own unpublished data). Not only HCA, but even cardiopulmonary
bypass without HCA, is associated with significant physiologic alterations in the
intestinal mucosal perfusion, epithelial permeability, edema formation, and blood
flow regulation. In a multivariate analysis of 775 consecutive patients who under-
went cardiac operations, HCA was a strong independent risk factor for postoperative
renal impairment.2
On the basis of the idea that hypothermia may be protective for all tissues,
profound cooling, as it is used clinically by the Mount Sinai group affiliated with
Randall Griepp, is considered to be the most essential and critical factor for organ
preservation.3 However, as has been mentioned before, deep hypothermia can cause
significant side-effects (ie, coagulation disorders) and increases considerably the
necessity for prolonged cardiopulmonary bypass time due to rewarming. As data
accumulate, indicating that expanded periods of extracorporeal circulation are
detrimental to the outcome, alternatives to profound hypothermia are needed to
increase the tolerance to ischemia, reduce the necessity of prolonged HCA, or to
decrease reperfusion injury after HCA.
Selective Perfusion Techniques
Clinically relevant perfusion-related concepts for single organ protection include the
use of retrograde cerebral perfusion and, more recently, a revival of an old tech-
nique—selective antegrade cerebral perfusion.3-5 Since there is increasing evidence
that nutritive function cannot be achieved via retrograde techniques,3 it seems that
retrograde cerebral perfusion lost its popularity in favor of a more liberal use of
selective antegrade cerebral perfusion. A detailed description and discussion con-
cerning the different techniques has been published in another editorial in this
Journal.3
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Drug Interventions
To increase the tolerance to ischemia, the use of potentially
neuroprotective drugs is an appealing concept, especially
since the circulatory arrest interval is well defined and
allows a preischemic treatment. Therefore, it is evident that
the use of these pharmaceuticals is more promising in HCA
patients than for the postischemic treatment of patients after
embolic strokes. Studies in a chronic porcine model showed
that nontoxic drugs are available that have neuroprotective
effects, making them potential candidates for clinical use.6
Additionally, combining drug treatment with selective per-
fusion techniques, to support adequate delivery of the agent
into the target organ, seems to be a promising concept.
Controlled Reperfusion
The idea of avoiding reperfusion injury for single organ
protection is well established and has been advocated by
different investigators. Allen, Buckberg, and coworkers7
described in a piglet model in this issue of the Journal a new
concept to avoid a “whole body reperfusion injury,” offer-
ing an exciting opportunity to protect organs that have been
subjected to prolonged periods of HCA. Accordingly, the
compounds of the “reperfusate” have been chosen to pro-
hibit what we know are important features of the reperfu-
sion injury.
It is generally accepted that high concentrations of cal-
cium can lead to an unphysiologic activation of proteases,
kinases, phosphatases, and endonucleases and trigger detri-
mental cascades. Furthermore, cell calcium overload in
combination with acidosis increases the production of re-
duced oxygen species, thus predisposing to free radical-
related damage.8 Therefore, efforts were made to reduce the
ionized calcium concentration, as well as the production of
free radicals. Allen and coworkers7 used a combination of
citrate, magnesium, and the indirect action of the sodium
hydrogen ion exchange inhibitor HOE 642. Moreover, man-
nitol has been added to the reperfusate, not only to scavenge
radicals, but to avoid edema formation, which is frequently
seen after HCA. In this context, there is still confusion
concerning the role of edema in the pathogenesis after HCA.
It is known that cardiopulmonary bypass, as well as HCA,
are associated with an overexpression of so-called acute
phase reactants. Some of these can cause “capillary leak
syndrome” with an extravasation of proteins and water
across cellular membranes. Despite the obvious clinical
observation of tissue edema in some of the patients after
HCA, it is not known whether this is a cause rather than a
reflection of tissue damage. Independent of the underlying
pathophysiology, there is evidence from experimental data
that even a slight increase of the intracranial pressure—
indicating cerebral edema—showed an inverse correlation
with the outcome after HCA.9 In this context, we do not
share the authors’ opinion that pH-stat is the ideal strategy
for cooling, rewarming, and reperfusion. We agree that
pH-stat may have an advantage in achieving thorough cool-
ing (by abolishing autoregulation), but we, like others,10
believe that the pH-stat-induced cerebral vasodilation, caus-
ing “luxury perfusion” during rewarming, increases the risk
for microembolization and macroembolization and actually
aggravates tissue edema. On the basis of these consider-
ations and the findings of Skaryak and coworkers,11 it seems
logical to initiate cooling with pH-stat, while rewarming
should be performed under alpha-stat conditions. Since re-
warming is probably the most crucial phase of the perfusion,
and since cerebrovascular resistance, blood flow, and en-
ergy demand change continuously with the changes in tem-
perature, slow warming should be performed, and the gra-
dient between perfusate temperature and core temperature
should never exceed 10°C. In this context, it is interesting to
note that even a short period of cold reperfusion can inhibit
the rise in intracranial pressure, suggesting that initial cold
reperfusion may decrease cerebral edema, thereby improv-
ing the outcome after prolonged HCA.12
Free radicals are highly reactive molecules implicated in
the cause of ischemic tissue injury through a mechanism
known as oxidative stress. The generation of these reactive
oxygen and reactive nitrogen compounds has been shown to
destroy cell membranes and to be detrimental for the sur-
vival of the cells. Studies in neuronal tissue showed an
interaction between the formation of radicals and apoptotic
cell death. Inasmuch as apoptosis is involved in the patho-
genesis of tissue damage after HCA,13 avoiding hyperoxia
and therefore reducing the formation of free radicals may
reduce cell death after HCA.
Another approach in protecting organs from reperfusion
injury is the depletion of leukocytes, based on the principle
of the avoidance of a tissue infiltration with mononuclear
cells. However, the discussion about the efficiency of leu-
kocyte-depleting filters is controversial. Rimpilainen and
coworkers,14 using a chronic porcine model, demonstrated
that leukocyte depletion significantly improved brain pro-
tection during 75 minutes of HCA at 20°C, whereas Lan-
gley and associates15 could not demonstrate a significant
improvement in a less severe neonatal piglet model of 60
minutes of HCA at 18°C. Since it has been demonstrated
that cardiopulmonary bypass and circulatory arrest can trig-
ger neutrophil adhesion to the endothelium and subsequent
transmigration, techniques to avoid such an interaction
seemed to be promising. Experimental data in small animals
suggest that blocking the expression of endothelial adhesion
molecules with specific antibodies has cell-protective ef-
fects.
In conclusion, the group affiliated with Gerald Buckberg
introduced a fascinating new concept of “whole body pro-
tection” after HCA. Because of the current tendency to
avoid general profound cooling and to rely on isolated
cerebral perfusion, an adequate protection of the remaining
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ischemic organs, other than hypothermia, will be needed to
avoid complications. The new approach demonstrated by
the group from the University of California at Los Angeles
offers the basis for further research in this important and
exciting field.
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